Literature DB >> 1968221

Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.

S P Cole1, H F Downes, S E Mirski, D J Clements.   

Abstract

H69AR is a multidrug-resistant small cell lung cancer cell line derived from a drug-sensitive cell line, H69, by selection in doxorubicin. It is cross-resistant to a wide variety of natural product-type antineoplastic agents but does not overexpress P-glycoprotein. In the present study, the levels of GSH and GSH-related enzymes in the H69AR cell line were determined and compared with those found in H69 cells. Unlike other drug-resistant cell lines, GSH levels were diminished 6-fold in H69AR cells (0.67 +/- 0.28 microgram/mg of protein), compared with H69 cells (4.23 +/- 1.17 micrograms/mg of protein) (p less than 0.01). This unusually low level of GSH may explain the pronounced collateral sensitivity of H69AR cells to buthionine sulfoximine (BSO), an inhibitor of the rate-limiting enzyme in GSH biosynthesis (ID50 of 4.4 microM BSO for H69AR cells versus ID50 of 300 microM BSO for H69 cells). BSO did not enhance doxorubicin cytotoxicity in the H69AR cell line, despite further depletion of GSH. GSH-reductase (EC 1.6.4.2) activity was elevated 2-fold in H69AR cells, compared with sensitive H69 cells (75.34 +/- 14.94 versus 38.62 +/- 5.06 nmol of NADPH/min/mg of protein) (p less than 0.05). Both selenium-dependent and -independent GSH-peroxidase (EC 1.11.1.9) activities were unchanged in the resistant H69AR cell line, compared with its parent cell line. gamma-Glutamyl transpeptidase (EC 2.3.2.2) activity was 5-fold elevated in H69AR cells, compared with H69 cells (2.50 +/- 0.44 versus 0.46 +/- 0.21 nmol of p-nitroaniline/min/mg of protein) (p less than 0.01), whereas GSH-S-transferase (EC 2.5.1.18) activity was 10-fold higher (201.98 +/- 43.62 versus 19.77 +/- 1.72 nmol of 1-chloro-2,4-dinitrobenzene/min/mg of protein in H69AR and H69 cells, respectively) (p less than 0.01). The GSH-S-transferases from both cell lines were purified by affinity chromatography and immunoblot analysis identified the GSH-S-transferases as belonging to the anionic pi class. GSH-S-transferases from the mu or alpha classes were not detectable in either cell line. In conclusion, marked differences in GSH levels and the activities of three of four GSH-related enzymes were observed between the multidrug-resistant H69AR cell line and its parent cell line. Further study is required to determine whether these changes are causally related to the development of drug resistance in this model system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968221

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  19 in total

1.  Glutathione S-transferase pi in an arsenic-resistant Chinese hamster ovary cell line.

Authors:  J F Lo; H F Wang; M F Tam; T C Lee
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

2.  Antioxidant and glutathione-associated enzymes in Wilms' tumour after chemotherapy.

Authors:  J Gajewska; M Szczypka; T Izbicki; T Klepacka; T Laskowska-Klita
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1).

Authors:  Lisa P Rudd; Sandra L Kabler; Charles S Morrow; Alan J Townsend
Journal:  Chem Biol Interact       Date:  2011-09-08       Impact factor: 5.192

Review 4.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

5.  Infection of H69AR cells with retroviral particles harboring interfering RNAi significantly reduced the multidrug resistance of these small cell lung cancer cells.

Authors:  Kanagaraj Palaniyandi; Qing Zhao; Xiu-Bao Chang
Journal:  Int J Biochem Mol Biol       Date:  2011-04-22

6.  Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.

Authors:  Wei Zhang; Jun Deng; Manjula Sunkara; Andrew J Morris; Chi Wang; Daret St Clair; Mary Vore
Journal:  J Pharmacol Exp Ther       Date:  2015-09-09       Impact factor: 4.030

7.  Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs.

Authors:  P Perego; A Boiardi; N Carenini; M De Cesare; E Dolfini; I Magnani; S Martignone; A Silvani; C Soranzo
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 8.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

9.  Isozyme specificity of novel glutathione-S-transferase inhibitors.

Authors:  J E Flatgaard; K E Bauer; L M Kauvar
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.

Authors:  M Clynes; A Redmond; E Moran; U Gilvarry
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.